Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Watson Pharmaceuticals Inc. (WPI)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: WPI
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Many Reasons to Launch a Global Generic Drug ETF
Dec 24
•
Mike Havrilla
•
4 Comments
Watson Pharmaceutical Financial Gauge Analysis for the September 2009 Quarter
Nov 25
•
Neil Carvin
•
Comment!
20 Large Cap Opportunities
Nov 24
•
Value Expectations
•
Comment!
Watson Pharmaceuticals: Income Statement Analysis for the September 2009 Quarter
Nov 8
•
Neil Carvin
•
Comment!
The Best and Worst International ETFs in 2009
Nov 8
•
Moby Waller
•
1 Comment
Cephalon's Upside and Downside
Nov 8
•
MagicDiligence
•
Comment!
Wall Street Breakfast: Must-Know News
Nov 4
•
SA Editor Eli Hoffmann
•
14 Comments
S&P 500 Stocks Up Since 10/9/07
Oct 8
•
Bespoke Investment Group
•
Comment!
Watson Pharma Look-Ahead to September 2009 Quarterly Results
Sep 23
•
Neil Carvin
•
Comment!
BioMed News Bytes: Arena, Momenta, Vivus
Sep 20
•
Mike Havrilla
•
Comment!
Q2 Gauge Scores: Summary
Sep 2
•
Neil Carvin
•
3 Comments
Mylan: Generic Drugmaker with a Strong Portfolio
Aug 28
•
BioPharma Investor
•
8 Comments
Teva Pharmaceutical: Predictable Growth, Good Value
Aug 20
•
Chuck Carnevale
•
9 Comments
Healthcare Sector Overview
Aug 18
•
Value Expectations
•
3 Comments
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 2
Aug 4
•
Pakiya
•
8 Comments
Caraco Pharmaceutical: Underappreciated and Undervalued, Part 1
Aug 4
•
Pakiya
•
Comment!
Watson Pharma Financial Gauge Analysis for June 2009 Quarter
Aug 4
•
Neil Carvin
•
Comment!
Watson Pharma Income Statement Analysis for June 2009 Quarter
Jul 30
•
Neil Carvin
•
Comment!
FDA Calendar Updates: Johnson & Johnson, Cadence, Watson, Targacept
Jul 16
•
Mike Havrilla
•
Comment!
FDA Calendar Updates: Still Waiting on BioDelivery Sciences
Jul 15
•
Mike Havrilla
•
6 Comments
Winners and Losers Since the 6/12 Market High
Jul 9
•
Bespoke Investment Group
•
Comment!
Healthcare: Branded Pharma Out, Diagnostics / Generics In
Jul 2
•
Ryan Barnes
•
Comment!
Watson Pharmaceuticals Says to Look Ahead to June 2009 Earnings
Jul 1
•
Neil Carvin
•
Comment!
Expect FDA Approval of AMAG Pharmaceutical's Feraheme
Jun 26
•
Kaushik Paul
•
16 Comments
Pharma Announces $80B Reduction: Who Wins?
Jun 23
•
Larry Rothman
•
1 Comment
A Healthy Dose of Funding for Pharma, Biotech
Jun 21
•
The Burrill Report
•
Comment!
FDA Calendar Updates: Trinity Biotech Awaiting Two Responses
Jun 11
•
Mike Havrilla
•
2 Comments
Health Care Trends Part 2: M&A, Generic Competition, CROs
Jun 7
•
Bullish Bankers
•
4 Comments
27 Earnings Season Growth Leaders
May 19
•
Trade Radar Operator
•
1 Comment
Wall Street Breakfast: Must-Know News
Apr 30
•
SA Editor Rachael Granby
•
15 Comments
FDA, Clinical Trial Updates: Watson Pharma, United Therapeutics, Auxilium, Dendreon
Apr 29
•
Mike Havrilla
•
1 Comment
FDA, Clinical Trial Calendar Updates: Genzyme, Isis, Osiris, Roche, Watson
Apr 23
•
Mike Havrilla
•
1 Comment
Tuesday Options Update: COH, WPI, HAL, XLB, ORCL & XLY
Apr 21
•
Andrew Wilkinson
•
Comment!
Impax Labs: Strong Balance Sheet, Focused R&D
Apr 21
•
Mike Havrilla
•
Comment!
Biotech Dip: Sector Weakness, or Buying Opportunity?
Mar 12
•
Hans Wagner
•
4 Comments
Momenta Pharma Pursuing a Three-Part Strategy
Mar 6
•
Mike Havrilla
•
Comment!
Biotech Going Generic Like Big Pharma?
Mar 2
•
Mike Havrilla
•
2 Comments
Best and Worst Performing S&P 500 Stocks Since 2/12
Feb 23
•
Bespoke Investment Group
•
Comment!
12 S&P 500 Stocks with Bullish Character in a Bearish Realm
Feb 20
•
Richard Shaw
•
7 Comments
Wall Street Breakfast: Must-Know News
Feb 19
•
SA Editor Rachael Granby
•
9 Comments
Updated Clinical Trial and FDA Calendars
Jan 29
•
Mike Havrilla
•
1 Comment
1
2
Next Page